Allspring Global Investments’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
9,032
+924
+11% +$39.1K ﹤0.01% 1527
2025
Q4
$369K Buy
8,108
+718
+10% +$30K ﹤0.01% 1462
2025
Q3
$260K Sell
7,390
-73
-1% -$2.54K ﹤0.01% 1513
2025
Q2
$226K Sell
7,463
-717
-9% -$20.5K ﹤0.01% 1524
2025
Q1
$244K Buy
+8,180
New +$250K ﹤0.01% 1621
2024
Q4
Sell
-79,822
Closed -$3.08M 1912
2024
Q3
$3.08M Buy
79,822
+36,331
+84% +$1.3M ﹤0.01% 1065
2024
Q2
$1.4M Sell
43,491
-1,947
-4% -$67.5K ﹤0.01% 1254
2024
Q1
$1.76M Sell
45,438
-424
-0.9% -$14.8K ﹤0.01% 1223
2023
Q4
$1.41M Buy
45,862
+4,192
+10% +$105K ﹤0.01% 1254
2023
Q3
$931K Buy
41,670
+37,946
+1,019% +$865K ﹤0.01% 1380
2023
Q2
$80K Buy
3,724
+1,182
+46% +$26.8K ﹤0.01% 2140
2023
Q1
$61K Buy
2,542
+581
+30% +$15.4K ﹤0.01% 2220
2022
Q4
$45.5K Sell
1,961
-43
-2% -$867 ﹤0.01% 2359
2022
Q3
$32K Buy
2,004
+245
+14% +$4.32K ﹤0.01% 2494
2022
Q2
$31K Sell
1,759
-64,158
-97% -$1.08M ﹤0.01% 2385
2022
Q1
$1.34M Sell
65,917
-15,142
-19% -$286K ﹤0.01% 1723
2021
Q4
$1.51M Buy
+81,059
New +$1.58M ﹤0.01% 1692

Other funds holding COLL

Allspring Global Investments's COLL Position: Q1 2026 in Review

Allspring Global Investments increased its Collegium Pharmaceutical (COLL) stake by 11% in Q1 2026, buying an estimated $39.1K and bringing the position to 9,032 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Allspring Global Investments first reported a position in COLL in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.08M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Allspring Global Investments held 9,032 shares of Collegium Pharmaceutical worth $300K as of Q1 2026.
  • Allspring Global Investments bought 924 Collegium Pharmaceutical shares in Q1 2026, an estimated $39.1K.
  • Collegium Pharmaceutical made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1527 holding.
  • Allspring Global Investments first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 17 quarters since.
  • Allspring Global Investments's Collegium Pharmaceutical position peaked at $3.08M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.